METROPOLITAN LIFE INSURANCE CO/NY - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 72 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,489
-20.2%
1,4340.0%0.00%
-100.0%
Q2 2023$10,6401,4340.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Intrepid Financial Planning Group LLC 18,000$106,5600.06%
PERRITT CAPITAL MANAGEMENT INC 12,000$71,0400.04%
CREATIVE FINANCIAL DESIGNS INC /ADV 16,625$98,4200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 63,966$378,6790.01%
Brandywine Global Investment Management, LLC 174,500$1,033,0400.01%
J. Goldman & Co LP 13,500$79,9200.00%
ROYCE & ASSOCIATES LP 50,000$296,0000.00%
Retirement Group, LLC 1,191$7,0510.00%
B. Riley Wealth Advisors, Inc. 14,550$86,1360.00%
Hartford Financial Management Inc. 598$3,5410.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders